▶ 調査レポート

世界の加齢黄斑変性症（AMD）の治療市場2019
• 英文タイトル：Global Age Related Macular Degeneration Treatment Sales Market Report 2019

QYResearchが調査・発行した産業分析レポートです。世界の加齢黄斑変性症（AMD）の治療市場2019 / Global Age Related Macular Degeneration Treatment Sales Market Report 2019 / QYR9M0124資料のイメージです。• レポートコード：QYR9M0124
• 出版社/出版日：QYResearch / 2019年4月30日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥592,000 (USD4,000)▷ お問い合わせ
  Enterprise License￥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
本調査レポートでは、加齢黄斑変性症（AMD）の治療の世界市場について調査・分析し、加齢黄斑変性症（AMD）の治療のメーカー別販売量、市場シェア分析、種類別販売分析（ルセンティス、アイリーア、アバスチン、その他）、用途別販売分析（病院、診療所、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・加齢黄斑変性症（AMD）の治療市場概要
・加齢黄斑変性症（AMD）の治療のメーカー別販売量・メーカー別シェア
・加齢黄斑変性症（AMD）の治療の種類別販売量（ルセンティス、アイリーア、アバスチン、その他）
・加齢黄斑変性症（AMD）の治療の用途別販売量（病院、診療所、その他）
・加齢黄斑変性症（AMD）の治療の地域別販売量・市場シェア
・加齢黄斑変性症（AMD）の治療の米国市場規模（2014年-2019年）
・加齢黄斑変性症（AMD）の治療のヨーロッパ市場規模（2014年-2019年）
・加齢黄斑変性症（AMD）の治療の中国市場規模（2014年-2019年）
・加齢黄斑変性症（AMD）の治療の日本市場規模（2014年-2019年）
・加齢黄斑変性症（AMD）の治療の東南アジア市場規模（2014年-2019年）
・加齢黄斑変性症（AMD）の治療のインド市場規模（2014年-2019年）
・加齢黄斑変性症（AMD）の治療メーカー分析（企業概要、製品概要、販売量、売上、価格等）
・加齢黄斑変性症（AMD）の治療のコスト分析
・加齢黄斑変性症（AMD）の治療販売チャネル、流通業者、顧客
・加齢黄斑変性症（AMD）の治療の世界市場動向・機会・成長要因・課題
・加齢黄斑変性症（AMD）の治療の種類別世界市場予測（ルセンティス、アイリーア、アバスチン、その他）
・加齢黄斑変性症（AMD）の治療の用途別世界市場予測（病院、診療所、その他）
・加齢黄斑変性症（AMD）の治療の米国市場予測（2019年-2025年）
・加齢黄斑変性症（AMD）の治療のヨーロッパ市場予測（2019年-2025年）
・加齢黄斑変性症（AMD）の治療の中国市場予測（2019年-2025年）
・加齢黄斑変性症（AMD）の治療の日本市場予測（2019年-2025年）
・加齢黄斑変性症（AMD）の治療の東南アジア市場予測（2019年-2025年）
・加齢黄斑変性症（AMD）の治療のインド市場予測（2019年-2025年）
...

Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
The global Age Related Macular Degeneration Treatment market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report studies the global Age Related Macular Degeneration Treatment market status and forecast, categorizes the global Age Related Macular Degeneration Treatment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
…

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Lucentis
Eylea
Avastin
Other

Segment by Application
Hospital
Clinic
Other

レポート目次

Table of Contents

Global Age Related Macular Degeneration Treatment Sales Market Report 2019
1 Age Related Macular Degeneration Treatment Market Overview
1.1 Age Related Macular Degeneration TreatmentProduct Overview
1.2 Age Related Macular Degeneration Treatment Segment by Type
1.2.1 Global Age Related Macular Degeneration Treatment Sales Comparison by Types (2014-2025)
1.2.2 Lucentis
1.2.3 Eylea
1.2.4 Avastin
1.2.5 Other
1.3 Age Related Macular Degeneration Treatment Segment by Application
1.3.1 Global Age Related Macular Degeneration Treatment Sales Comparison by Application (2014-2025)
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Other
1.4 Age Related Macular Degeneration Treatment Market by Region
1.4.1 Global Age Related Macular Degeneration Treatment Revenue Comparison by Region (2014-2025)
1.4.2 United States Age Related Macular Degeneration Treatment Status and Prospect (2014-2025)
1.4.3 Europe Age Related Macular Degeneration Treatment Status and Prospect (2014-2025)
1.4.4 China Age Related Macular Degeneration Treatment Status and Prospect (2014-2025)
1.4.5 Japan Age Related Macular Degeneration Treatment Status and Prospect (2014-2025)
1.4.6 Southeast Asia Age Related Macular Degeneration Treatment Status and Prospect (2014-2025)
1.4.7 India Age Related Macular Degeneration Treatment Status and Prospect (2014-2025)
1.5 Global Age Related Macular Degeneration Treatment Sales and Revenue (2014-2025)
1.5.1 Global Age Related Macular Degeneration Treatment Sales and Growth Rate (2014-2025)
1.5.2 Global Age Related Macular Degeneration Treatment Revenue and Growth Rate (2014-2025)

2 Age Related Macular Degeneration Treatment by Company, Region, Type and Application
2.1 Global Age Related Macular Degeneration Treatment Market Competition by Companies
2.1.1 Global Age Related Macular Degeneration Treatment Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Age Related Macular Degeneration Treatment Revenue Market Share by Company (2014-2019)
2.2 Global Age Related Macular Degeneration Treatment Sales and Revenue by Region
2.2.1 Global Age Related Macular Degeneration Treatment Sales Market Share by Region (2014-2019)
2.2.2 Global Age Related Macular Degeneration Treatment Revenue Market Share by Region (2014-2019)
2.3 Global Age Related Macular Degeneration Treatment Sales and Revenue by Type
2.3.1 Global Age Related Macular Degeneration Treatment Sales Market Share by Type (2014-2019)
2.3.2 Global Age Related Macular Degeneration Treatment Revenue Market Share by Type (2014-2019)
2.4 Global Age Related Macular Degeneration Treatment Sales by Application

3 United States Age Related Macular Degeneration Treatment Sales, Revenue and Price
3.1 United States Age Related Macular Degeneration Treatment Sales and Revenue (2014-2019)
3.1.1 United States Age Related Macular Degeneration Treatment Sales Growth Rate (2014-2019)
3.1.2 United States Age Related Macular Degeneration Treatment Revenue Growth Rate (2014-2019)
3.1.3 United States Age Related Macular Degeneration Treatment Price Trend (2014-2019)
3.2 United States Age Related Macular Degeneration Treatment Sales Market Share by Company
3.3 United States Age Related Macular Degeneration Treatment Sales Market Share by Type
3.4 United States Age Related Macular Degeneration Treatment Sales Market Share by Application

4 Europe Age Related Macular Degeneration Treatment Sales, Revenue and Price
4.1 Europe Age Related Macular Degeneration Treatment Sales and Value (2014-2019)
4.1.1 Europe Age Related Macular Degeneration Treatment Sales Growth Rate (2014-2019)
4.1.2 Europe Age Related Macular Degeneration Treatment Revenue Growth Rate (2014-2019)
4.1.3 Europe Age Related Macular Degeneration Treatment Price Trend (2014-2019)
4.2 Europe Age Related Macular Degeneration Treatment Sales Market Share by Company
4.3 Europe Age Related Macular Degeneration Treatment Sales Market Share by Type
4.4 Europe Age Related Macular Degeneration Treatment Sales Market Share by Application

5 China Age Related Macular Degeneration Treatment Sales, Revenue and Price
5.1 China Age Related Macular Degeneration Treatment Sales and Revenue (2014-2019)
5.1.1 China Age Related Macular Degeneration Treatment Sales Growth Rate (2014-2019)
5.1.2 China Age Related Macular Degeneration Treatment Revenue Growth Rate (2014-2019)
5.1.3 China Age Related Macular Degeneration Treatment Price Trend (2014-2019)
5.2 China Age Related Macular Degeneration Treatment Sales Market Share by Company
5.3 China Age Related Macular Degeneration Treatment Sales Market Share by Type
5.4 China Age Related Macular Degeneration Treatment Sales Market Share by Application

6 Japan Age Related Macular Degeneration Treatment Sales, Revenue and Price
6.1 Japan Age Related Macular Degeneration Treatment Sales and Value (2014-2019)
6.1.1 Japan Age Related Macular Degeneration Treatment Sales Growth Rate (2014-2019)
6.1.2 Japan Age Related Macular Degeneration Treatment Revenue Growth Rate (2014-2019)
6.1.3 Japan Age Related Macular Degeneration Treatment Price Trend (2014-2019)
6.2 Japan Age Related Macular Degeneration Treatment Sales Market Share by Company
6.3 Japan Age Related Macular Degeneration Treatment Sales Market Share by Type
6.4 Japan Age Related Macular Degeneration Treatment Sales Market Share by Application

7 Southeast Asia Age Related Macular Degeneration Treatment Sales, Revenue and Price
7.1 Southeast Asia Age Related Macular Degeneration Treatment Sales and Value (2014-2019)
7.1.1 Southeast Asia Age Related Macular Degeneration Treatment Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Age Related Macular Degeneration Treatment Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Age Related Macular Degeneration Treatment Price Trend (2014-2019)
7.2 Southeast Asia Age Related Macular Degeneration Treatment Sales Market Share by Company
7.3 Southeast Asia Age Related Macular Degeneration Treatment Sales Market Share by Type
7.4 Southeast Asia Age Related Macular Degeneration Treatment Sales Market Share by Application

8 India Age Related Macular Degeneration Treatment Sales, Revenue and Price
8.1 India Age Related Macular Degeneration Treatment Sales and Value (2014-2019)
8.1.1 India Age Related Macular Degeneration Treatment Sales Growth Rate (2014-2019)
8.1.2 India Age Related Macular Degeneration Treatment Revenue Growth Rate (2014-2019)
8.1.3 India Age Related Macular Degeneration Treatment Price Trend (2014-2019)
8.2 India Age Related Macular Degeneration Treatment Sales Market Share by Company
8.3 India Age Related Macular Degeneration Treatment Sales Market Share by Type
8.4 India Age Related Macular Degeneration Treatment Sales Market Share by Application

9 Company Profiles and Key Figures in Age Related Macular Degeneration Treatment Business
9.1 Regeneron Pharmaceuticals
9.1.1 Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Production Sites and Area Served
9.1.2 Age Related Macular Degeneration Treatment Specification and Application
9.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Bayer HealthCare
9.2.1 Bayer HealthCare Age Related Macular Degeneration Treatment Production Sites and Area Served
9.2.2 Age Related Macular Degeneration Treatment Specification and Application
9.2.3 Bayer HealthCare Age Related Macular Degeneration Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Novartis
9.3.1 Novartis Age Related Macular Degeneration Treatment Production Sites and Area Served
9.3.2 Age Related Macular Degeneration Treatment Specification and Application
9.3.3 Novartis Age Related Macular Degeneration Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Roche
9.4.1 Roche Age Related Macular Degeneration Treatment Production Sites and Area Served
9.4.2 Age Related Macular Degeneration Treatment Specification and Application
9.4.3 Roche Age Related Macular Degeneration Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Kanghong Pharma
9.5.1 Kanghong Pharma Age Related Macular Degeneration Treatment Production Sites and Area Served
9.5.2 Age Related Macular Degeneration Treatment Specification and Application
9.5.3 Kanghong Pharma Age Related Macular Degeneration Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
…

10 Age Related Macular Degeneration Treatment Maufacturing Cost Analysis
10.1 Age Related Macular Degeneration Treatment Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Age Related Macular Degeneration Treatment
10.4 Age Related Macular Degeneration Treatment Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Age Related Macular Degeneration Treatment Distributors List
11.3 Age Related Macular Degeneration Treatment Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Age Related Macular Degeneration Treatment Market Forecast
13.1 Global Age Related Macular Degeneration Treatment Sales, Revenue and Price Forecast
13.1.1 Global Age Related Macular Degeneration Treatment Sales Growth Forecast (2019-2025)
13.1.2 Global Age Related Macular Degeneration Treatment Revenue Growth Forecast (2019-2025)
13.1.3 Global Age Related Macular Degeneration Treatment Price Trend Forecast (2019-2025)
13.2 Global Age Related Macular Degeneration Treatment Forecast by Region
13.2.1 Global Age Related Macular Degeneration Treatment Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Age Related Macular Degeneration Treatment Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Age Related Macular Degeneration Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Age Related Macular Degeneration Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Age Related Macular Degeneration Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Age Related Macular Degeneration Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Age Related Macular Degeneration Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Age Related Macular Degeneration Treatment Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Age Related Macular Degeneration Treatment Forecast by Type
13.3.1 Global Age Related Macular Degeneration Treatment Sales Forecast by Type (2019-2025)
13.3.2 Global Age Related Macular Degeneration Treatment Revenue Forecast by Type (2019-2025)
13.3.3 Global Age Related Macular Degeneration Treatment Price Forecast by Type (2019-2025)
13.4 Global Age Related Macular Degeneration Treatment Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

List of Tables and Figures

Market Breakdown by Region: Age Related Macular Degeneration Treatment Sales (K Units) and Value (Revenue: Million US$)
Market Breakdown by Type: Age Related Macular Degeneration Treatment Sales (K Units) and Revenue (Million US$)
Market Breakdown by Application: Age Related Macular Degeneration Treatment Sales (Feb)
Figure Age Related Macular Degeneration Treatment Product Picture
Table Global Age Related Macular Degeneration Treatment Sales (K Units) Growth Rate by Types (2014-2025)
Figure Global Age Related Macular Degeneration Treatment Sales Market Share by Types in 2018
Figure Lucentis Product Picture
Figure Eylea Product Picture
Figure Avastin Product Picture
Figure Other Product Picture
Table Global Age Related Macular Degeneration Treatment Sales (K Units) Comparison by Application (2014-2025)
Figure Global Sales Market Share of Age Related Macular Degeneration Treatment by Application in 2018
Figure Hospital Examples
Figure Clinic Examples
Figure Other Examples
Table Global Market Age Related Macular Degeneration Treatment Revenue (Million USD) Comparison by Region 2014-2025
Figure United States Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Age Related Macular Degeneration Treatment Sales (K Units) Growth Rate (2014-2025)
Figure Global Age Related Macular Degeneration Treatment Revenue (Million USD) Growth Rate (2014-2025)
Table Global Age Related Macular Degeneration Treatment Sales (K Units) of Key Companies (2014-2019)
Figure Global Age Related Macular Degeneration Treatment Sales by Company in 2018
Table Global Age Related Macular Degeneration Treatment Sales Share by Company (2014-2019)
Figure Global Age Related Macular Degeneration Treatment Sales Share by Company in 2018
Table Global Age Related Macular Degeneration Treatment Revenue (Million USD) by Company (2014-2019)
Figure Global Age Related Macular Degeneration Treatment Revenue (Million USD) by Company in 2018
Table Global Age Related Macular Degeneration Treatment Revenue Share by Company (2014-2019)
Figure Global Age Related Macular Degeneration Treatment Revenue Share by Company in 2018
Table Global Age Related Macular Degeneration Treatment Sales (K Units) Market Share by Region (2014-2019)
Table Global Age Related Macular Degeneration Treatment Sales Share by Region (2014-2019)
Figure Global Age Related Macular Degeneration Treatment Sales Share by Region in 2018
Table Global Age Related Macular Degeneration Treatment Revenue (Million USD) Market Share by Region (2014-2019)
Table Global Age Related Macular Degeneration Treatment Revenue Share by Region (2014-2019)
Figure Global Age Related Macular Degeneration Treatment Revenue Market Share by Region In 2018
Table Global Age Related Macular Degeneration Treatment Sales (K Units) by Type (2014-2019)
Table Global Age Related Macular Degeneration Treatment Sales Share by Type (2014-2019)
Figure Global Age Related Macular Degeneration Treatment Sales Growth Rate by Type in 2018
Table Global Age Related Macular Degeneration Treatment Revenue (Million USD) Market Share by Type (2014-2019)
Table Global Age Related Macular Degeneration Treatment Revenue Share by Type (2014-2019)
Figure Global Age Related Macular Degeneration Treatment Revenue Growth Rate by Type in 2018
Table Global Age Related Macular Degeneration Treatment Sales Market Share by Application (2014-2019)
Table Global Age Related Macular Degeneration Treatment Sales Share by Application (2014-2019)
Figure Global Age Related Macular Degeneration Treatment Sales Market Share by Application in 2018
Figure United States Age Related Macular Degeneration Treatment Sales (K Units) and Growth Rate (2014-2019)
Figure United States Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure United States Age Related Macular Degeneration Treatment Price (USD/Unit) Trend (2014-2019)
Table United States Age Related Macular Degeneration Treatment Sales (K Units) by Company (2014-2019)
Table United States Age Related Macular Degeneration Treatment Sales Market Share by Company (2014-2019)
Figure United States Age Related Macular Degeneration Treatment Sales Market Share by Company in 2018
Table United States Age Related Macular Degeneration Treatment Sales (K Units) by Type (2014-2019)
Table United States Age Related Macular Degeneration Treatment Sales Market Share by Type (2014-2019)
Figure United States Age Related Macular Degeneration Treatment Sales Market Share by Type in 2018
Table United States Age Related Macular Degeneration Treatment Sales (K Units) by Application (2014-2019)
Table United States Age Related Macular Degeneration Treatment Sales Market Share by Application (2014-2019)
Figure United States Age Related Macular Degeneration Treatment Sales Market Share by Application in 2018
Figure Europe Age Related Macular Degeneration Treatment Sales (K Units) and Growth Rate (2014-2019)
Figure Europe Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Europe Age Related Macular Degeneration Treatment Price (USD/Unit) Trend (2014-2019)
Table Europe Age Related Macular Degeneration Treatment Sales (K Units) by Company (2014-2019)
Table Europe Age Related Macular Degeneration Treatment Sales Market Share by Company (2014-2019)
Figure Europe Age Related Macular Degeneration Treatment Sales Market Share by Company in 2018
Table Europe Age Related Macular Degeneration Treatment Sales (K Units) by Type (2014-2019)
Table Europe Age Related Macular Degeneration Treatment Sales Market Share by Type (2014-2019)
Figure Europe Age Related Macular Degeneration Treatment Sales Market Share by Type in 2018
Table Europe Age Related Macular Degeneration Treatment Sales (K Units) by Application (2014-2019)
Table Europe Age Related Macular Degeneration Treatment Sales Market Share by Application (2014-2019)
Figure Europe Age Related Macular Degeneration Treatment Sales Market Share by Application in 2018
Figure China Age Related Macular Degeneration Treatment Sales (K Units) and Growth Rate (2014-2019)
Figure China Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure China Age Related Macular Degeneration Treatment Price (USD/Unit) Trend (2014-2019)
Table China Age Related Macular Degeneration Treatment Sales (K Units) by Company (2014-2019)
Table China Age Related Macular Degeneration Treatment Sales Market Share by Company (2014-2019)
Figure China Age Related Macular Degeneration Treatment Sales Market Share by Company in 2018
Table China Age Related Macular Degeneration Treatment Sales (K Units) by Type (2014-2019)
Table China Age Related Macular Degeneration Treatment Sales Market Share by Type (2014-2019)
Figure China Age Related Macular Degeneration Treatment Sales Market Share by Type in 2018
Table China Age Related Macular Degeneration Treatment Sales (K Units) by Application (2014-2019)
Table China Age Related Macular Degeneration Treatment Sales Market Share by Application (2014-2019)
Figure China Age Related Macular Degeneration Treatment Sales Market Share by Application in 2018
Figure Japan Age Related Macular Degeneration Treatment Sales (K Units) and Growth Rate (2014-2019)
Figure Japan Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Japan Age Related Macular Degeneration Treatment Price (USD/Unit) Trend (2014-2019)
Table Japan Age Related Macular Degeneration Treatment Sales (K Units) by Company (2014-2019)
Table Japan Age Related Macular Degeneration Treatment Sales Market Share by Company (2014-2019)
Figure Japan Age Related Macular Degeneration Treatment Sales Market Share by Company in 2018
Table Japan Age Related Macular Degeneration Treatment Sales (K Units) by Type (2014-2019)
Table Japan Age Related Macular Degeneration Treatment Sales Market Share by Type (2014-2019)
Figure Japan Age Related Macular Degeneration Treatment Sales Market Share by Type in 2018
Table Japan Age Related Macular Degeneration Treatment Sales (K Units) by Application (2014-2019)
Table Japan Age Related Macular Degeneration Treatment Sales Market Share by Application (2014-2019)
Figure Japan Age Related Macular Degeneration Treatment Sales Market Share by Application in 2018
Figure Southeast Asia Age Related Macular Degeneration Treatment Sales (K Units) and Growth Rate (2014-2019)
Figure Southeast Asia Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Southeast Asia Age Related Macular Degeneration Treatment Price (USD/Unit) Trend (2014-2019)
Table Southeast Asia Age Related Macular Degeneration Treatment Sales (K Units) by Company (2014-2019)
Table Southeast Asia Age Related Macular Degeneration Treatment Sales Market Share by Company (2014-2019)
Figure Southeast Asia Age Related Macular Degeneration Treatment Sales Market Share by Company in 2018
Table Southeast Asia Age Related Macular Degeneration Treatment Sales (K Units) by Type (2014-2019)
Table Southeast Asia Age Related Macular Degeneration Treatment Sales Market Share by Type (2014-2019)
Figure Southeast Asia Age Related Macular Degeneration Treatment Sales Market Share by Type in 2018
Table Southeast Asia Age Related Macular Degeneration Treatment Sales (K Units) by Application (2014-2019)
Table Southeast Asia Age Related Macular Degeneration Treatment Sales Market Share by Application (2014-2019)
Figure Southeast Asia Age Related Macular Degeneration Treatment Sales Market Share by Application in 2018
Figure India Age Related Macular Degeneration Treatment Sales (K Units) and Growth Rate (2014-2019)
Figure India Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure India Age Related Macular Degeneration Treatment Price (USD/Unit) Trend (2014-2019)
Table India Age Related Macular Degeneration Treatment Sales (K Units) by Company (2014-2019)
Table India Age Related Macular Degeneration Treatment Sales Market Share by Company (2014-2019)
Figure India Age Related Macular Degeneration Treatment Sales Market Share by Company in 2018
Table India Age Related Macular Degeneration Treatment Sales (K Units) by Type (2014-2019)
Table India Age Related Macular Degeneration Treatment Sales Market Share by Type (2014-2019)
Figure India Age Related Macular Degeneration Treatment Sales Market Share by Type in 2018
Table India Age Related Macular Degeneration Treatment Sales (K Units) by Application (2014-2019)
Table India Age Related Macular Degeneration Treatment Sales Market Share by Application (2014-2019)
Figure India Age Related Macular Degeneration Treatment Sales Market Share by Application in 2018
Table Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Production Sites and Area Served
Table Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Specification and Application
Table Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Sales Growth Rate (2014-2019)
Figure Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Revenue Share in International Market (2014-2019)
Figure Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Main Business and Markets Served
Table Bayer HealthCare Age Related Macular Degeneration Treatment Production Sites and Area Served
Table Bayer HealthCare Age Related Macular Degeneration Treatment Specification and Application
Table Bayer HealthCare Age Related Macular Degeneration Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Bayer HealthCare Age Related Macular Degeneration Treatment Sales Growth Rate (2014-2019)
Figure Bayer HealthCare Age Related Macular Degeneration Treatment Revenue Share in International Market (2014-2019)
Figure Bayer HealthCare Age Related Macular Degeneration Treatment Main Business and Markets Served
Table Novartis Age Related Macular Degeneration Treatment Production Sites and Area Served
Table Novartis Age Related Macular Degeneration Treatment Specification and Application
Table Novartis Age Related Macular Degeneration Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Novartis Age Related Macular Degeneration Treatment Sales Growth Rate (2014-2019)
Figure Novartis Age Related Macular Degeneration Treatment Revenue Share in International Market (2014-2019)
Figure Novartis Age Related Macular Degeneration Treatment Main Business and Markets Served
Table Roche Age Related Macular Degeneration Treatment Production Sites and Area Served
Table Roche Age Related Macular Degeneration Treatment Specification and Application
Table Roche Age Related Macular Degeneration Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Roche Age Related Macular Degeneration Treatment Sales Growth Rate (2014-2019)
Figure Roche Age Related Macular Degeneration Treatment Revenue Share in International Market (2014-2019)
Figure Roche Age Related Macular Degeneration Treatment Main Business and Markets Served
Table Kanghong Pharma Age Related Macular Degeneration Treatment Production Sites and Area Served
Table Kanghong Pharma Age Related Macular Degeneration Treatment Specification and Application
Table Kanghong Pharma Age Related Macular Degeneration Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Kanghong Pharma Age Related Macular Degeneration Treatment Sales Growth Rate (2014-2019)
Figure Kanghong Pharma Age Related Macular Degeneration Treatment Revenue Share in International Market (2014-2019)
Figure Kanghong Pharma Age Related Macular Degeneration Treatment Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Key Raw Materials Price Trend
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Age Related Macular Degeneration Treatment
Figure Manufacturing Process Analysis of Age Related Macular Degeneration Treatment
Figure Age Related Macular Degeneration Treatment Industrial Chain Analysis
Table Age Related Macular Degeneration Treatment Distributors List
Table Age Related Macular Degeneration Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Age Related Macular Degeneration Treatment Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Global Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Age Related Macular Degeneration Treatment Price (USD/Unit) and Trend Forecast (2019-2025)
Table Global Age Related Macular Degeneration Treatment Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Age Related Macular Degeneration Treatment Sales Market Share Forecast by Regions (2019-2025)
Figure Global Age Related Macular Degeneration Treatment Sales Market Share Forecast by Regions in 2025
Table Global Age Related Macular Degeneration Treatment Revenue (Million USD) Forecast by Regions (2019-2025)
Figure Global Age Related Macular Degeneration Treatment Revenue Market Share Forecast by Regions (2019-2025)
Figure Global Age Related Macular Degeneration Treatment Revenue Market Share Forecast by Regions in 2025
Figure United States Age Related Macular Degeneration Treatment Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure United States Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Age Related Macular Degeneration Treatment Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Europe Age Related Macular Degeneration Treatment Revenue and Growth Rate Forecast (2019-2025)
Figure China Age Related Macular Degeneration Treatment Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure China Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Age Related Macular Degeneration Treatment Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Japan Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Age Related Macular Degeneration Treatment Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure India Age Related Macular Degeneration Treatment Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure India Age Related Macular Degeneration Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Age Related Macular Degeneration Treatment Sales (K Units) Forecast by Type (2019-2025)
Figure Global Age Related Macular Degeneration Treatment Sales Market Share Forecast by Type (2019-2025)
Table Global Age Related Macular Degeneration Treatment Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Age Related Macular Degeneration Treatment Revenue Market Share Forecast by Type (2019-2025)
Table Global Age Related Macular Degeneration Treatment Price (USD/Unit) Forecast by Type (2019-2025)
Table Global Age Related Macular Degeneration Treatment Sales (K Units) Forecast by Application (2019-2025)
Figure Global Age Related Macular Degeneration Treatment Sales Market Share Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の加齢性黄斑変性症（AMD）市場2019
    Global Age-related Macular Degeneration Sales Market Report 2019
    QYR9M0125 2019年4月30日 116Pages
    本調査レポートでは、加齢性黄斑変性症（AMD）の世界市場について調査・分析し、加齢性黄斑変性症（AMD）のメーカー別販売量、市場シェア分析、種類別販売分析（ウェット型、ドライ型）、用途別販売分析（ドラッグストア、病院、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格...
  • 黄斑変性症治療の世界市場分析・規模・シェア・成長・動向・予測：適応症別（ドライタイプ加齢黄斑変性症（dAMD）、ウェットタイプ加齢黄斑変性症（wAMD））、薬剤クラス別（抗血管内皮増殖因子、その他）、流通経路別（病院、眼科診療所、通院外科診療所）
    Macular Degeneration Treatment Market (Disease Indication - Dry Age related Macular Degeneration (dAMD), Wet Age-related Macular Degeneration (wAMD); Drug Class - Anti Vascular Endothelial Growth Factor and Others; Distribution Channel - Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
    TPM-C03110 2019年2月15日 195Pages
    本資料は、黄斑変性症治療の世界市場について調べ、黄斑変性症治療の世界規模、市場動向、市場環境、適応症別（ドライタイプ加齢黄斑変性症（dAMD）、ウェットタイプ加齢黄斑変性症（wAMD））分析、薬剤クラス別（抗血管内皮増殖因子、その他）分析、流通経路別（病院、眼科診療所、通院外科診療所）分析、アメリカ...
  • 黄斑変性症治療の世界市場2022-2031：産業分析、規模、シェア、成長、動向、予測
    Macular Degeneration Treatment Market (Disease Indication: Wet Age-related Macular Degeneration, Dry Age-related Macular Degeneration, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
    MRC2211A091 2022年9月 195Pages
    トレンスペアレンシーマーケットリサーチ社の当調査レポートでは、世界の黄斑変性症治療市場を総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、疾患別（湿性加齢黄斑変性症、乾性加齢黄斑変性症、その他）分析、薬剤分類別（抗血管内皮増殖因子、その他）分析、流通チャネ...
  • 世界の若年性黄斑変性症（シュタルガルト病）治療市場規模・現状・予測（2021年-2027年）
    Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size, Status and Forecast 2021-2027
    QYR2104Z3306 2021年4月15日 93Pages
    QYResearch社発行の本調査資料では、若年性黄斑変性症（シュタルガルト病）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（幹細胞治療、遺伝子治療、その他）、用途別市場規模（病院、眼科クリニック、その他）、主要地域別市場規模（北米、アメ...
  • 世界の加齢黄斑変性症市場（～2027）：種類別、治療別、流通チャネル別、地域別
    Age-related Macular Degeneration Market Research Report by Type, Treatment Type, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
    360iR22DE128 2022年10月 230Pages
    360iResearch社の本調査レポートは、2021年に9,835.55百万ドルであった世界の加齢黄斑変性症市場規模が、2022年に11,413.18百万ドルになり、2027年まで年平均16.29％で成長して24,331.26百万ドルに達すると予測しています。本レポートでは、加齢黄斑変性症の世界市...